CTRI/2019/04/018785已完成未知
EFFECT OF PLATELET RICH FIBRIN AND DEMINERALIZED FREEZE DRIED BONE ALLOGRAFT IN COMBINATION WITH SINGLE FLAP APPROACH IN THE REGENERATIVE TREATMENT OF INTRAOSSEOUS DEFECTS - A RANDOMIZED CONTROLLED CLINICAL TRIAL. - SFA
Manipal College Of Dental SciencesMangalore0 个研究点目标入组 10 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients who agree to participate in the study by signing the informed consent.
- •2.Age >=18 years
- •3.Full mouth plaque index score <20% and full mouth modified sulcular bleeding index score <20%.
- •4.Patients diagnosed with chronic periodontitis. 5. Presence of at least one intra-osseous defect with presurgical PD >= 5 mm and radiographic depth (as assessed on periapical radiograph) >= 3 mm; limited to no extension of the periodontal intraosseous defect on the lingual/palatal side as assessed by pre-operative bone sounding.
排除标准
- •1. Patients with systemically compromised health.
- •2. Periodontal surgical treatment during the previous 24 months in the involved site.
- •3. Pregnant or lactating women.
- •4. Non-compliant patients.
- •5. Restorations and superficial caries in the area to be treated.
- •6. Fully restored teeth.
- •7. Third molars and teeth with grade III mobility 8. furcation involvement 9. inadequate endodontic treatment and/or restoration
研究者
相似试验
尚未招募
不适用
EFFECT OF ADVANCED PLATELET RICH FIBRIN (A-PRF) IN THE TREATMENT OF PERIODONTAL INTRABONY DEFECTSCTRI/2019/07/020175Dr Md Naseem Ashraf
尚未招募
4 期
se of Patients own blood factors in wrinkles around eyesCTRI/2021/07/034785MGM Hospital Aurangabad
已完成
不适用
A Randomised control trial to evaluate the efficacy of Platelet rich Fibrin in bone regeneration after putting it in the socket of extracted third molar of mandibleCTRI/2019/07/020259Praneet K Rana65
尚未招募
3 期
Effect of platelet rich fibrin (derived from blood) on orthodontic treatment duratioCTRI/2023/09/057788Dr Sonar Kapil Mahendra
招募中
1 期
Treatment of bone loss around teeth by products derived from partcipants bloodCTRI/2019/02/017673Manne Sreehitha
